These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 26857892

  • 1. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
    Rychert M, Wilkins C.
    Drug Test Anal; 2016 Aug; 8(8):768-78. PubMed ID: 26857892
    [Abstract] [Full Text] [Related]

  • 2. Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand.
    Rychert M, Wilkins C, Witten K.
    Drug Alcohol Rev; 2017 Sep; 36(5):589-596. PubMed ID: 28229493
    [Abstract] [Full Text] [Related]

  • 3. The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution.
    Rychert M, Wilkins C.
    Int J Drug Policy; 2015 Dec; 26(12):1273-8. PubMed ID: 26364077
    [Abstract] [Full Text] [Related]

  • 4. Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.
    Rychert M, Wilkins C.
    Int J Drug Policy; 2016 Nov; 37():90-97. PubMed ID: 27639994
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory.
    Rychert M, Wilkins C.
    Addiction; 2018 Nov; 113(11):2132-2139. PubMed ID: 29744945
    [Abstract] [Full Text] [Related]

  • 9. Thirty-one psychoactive plants exempted from New Zealand's Psychoactive Substances Act 2013.
    Rychert M, Wilkins C.
    Addiction; 2017 Jan; 112(1):181-182. PubMed ID: 27549982
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The New Zealand Psychoactive Substances Act (PSA): a policy breakthrough or just a symbolic act?
    Bretteville-Jensen AL.
    Addiction; 2014 Oct; 109(10):1590-1. PubMed ID: 25163706
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Is the recent ban on animal testing of legal high products a fatal blow to the development of a legal market for 'low-risk' psychoactive products in New Zealand?
    Rychert M, Wilkins C.
    Addiction; 2015 Apr; 110(4):714-5. PubMed ID: 25771695
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.
    Deen AA, Claridge H, Treble RD, Hamnett HJ, Copeland CS.
    J Psychopharmacol; 2021 Nov; 35(11):1315-1323. PubMed ID: 34182812
    [Abstract] [Full Text] [Related]

  • 16. Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill.
    Reuter P, Pardo B.
    Addiction; 2017 Jan; 112(1):25-31. PubMed ID: 27220685
    [Abstract] [Full Text] [Related]

  • 17. 'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate.
    Corazza O, Demetrovics Z, van den Brink W, Schifano F.
    Int J Drug Policy; 2013 Jan; 24(1):82-3. PubMed ID: 22883544
    [No Abstract] [Full Text] [Related]

  • 18. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand.
    Rychert M, Wilkins C, Parker K, Witten K.
    Drug Alcohol Rev; 2018 Mar; 37(3):406-413. PubMed ID: 29285812
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New psychoactive substances: Are there any good options for regulating new psychoactive substances?
    Reuter P, Pardo B.
    Int J Drug Policy; 2017 Feb; 40():117-122. PubMed ID: 27889115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.